Nxera Pharma

Nxera Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates. Nxera employs over 350 talented people at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).
Looking for a particular Nxera Pharma employee's phone or email?

Nxera Pharma Questions

News

The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders - ACS Publications

The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders ACS Publications

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million - Yahoo Finance

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million Yahoo Finance

First 90 Days: Sosei Heptares’ Chris Cargill - PharmaVoice

First 90 Days: Sosei Heptares’ Chris Cargill PharmaVoice

Sosei Heptares hails ‘transformational’ acquisition - Labiotech.eu

Sosei Heptares hails ‘transformational’ acquisition Labiotech.eu

GSK research revamp sees Sosei Heptares-licensed drug culled from pipeline - FirstWord Pharma

GSK research revamp sees Sosei Heptares-licensed drug culled from pipeline FirstWord Pharma

Aditum Bio, Co-Founded by Novartis Veterans Joe Jimenez and Dr. Mark Fishman, forms Second Company - PR Newswire

Aditum Bio, Co-Founded by Novartis Veterans Joe Jimenez and Dr. Mark Fishman, forms Second Company PR Newswire

Lilly pens $730M biobucks deal with Sosei Heptares to get in on GPCR action - Fierce Biotech

Lilly pens $730M biobucks deal with Sosei Heptares to get in on GPCR action Fierce Biotech

Sosei Heptares and AbbVie Partner on Inflammatory and Autoimmune Diseases - BioSpace

Sosei Heptares and AbbVie Partner on Inflammatory and Autoimmune Diseases BioSpace

Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein–Ligand Complexes - ACS Publications

Novel Macrocyclic Antagonists of the Calcitonin Gene-Related Peptide Receptor: Design, Realization, and Structural Characterization of Protein–Ligand Complexes ACS Publications

Sosei Heptares and Aditum Bio to advance clinical program for neurological diseases - BioSpectrum Asia

Sosei Heptares and Aditum Bio to advance clinical program for neurological diseases BioSpectrum Asia

Sosei Heptares pens $1B biobucks GPCR pact with Genentech - Fierce Biotech

Sosei Heptares pens $1B biobucks GPCR pact with Genentech Fierce Biotech

Alchemical Free Energy Calculations on Membrane-Associated Proteins - ACS Publications

Alchemical Free Energy Calculations on Membrane-Associated Proteins ACS Publications

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant